LAD shorts ease as options pivot signals sentiment shift

Lithia Motors enters its earnings week with a notable divergence: short sellers have been quietly reducing positions even as the Street has spent the past month cutting price targets across the board.

Short interest has drifted lower, now running at 7.9% of the free float, down roughly 1.3% on the week. That is not a dramatic unwind, but the direction is clear, and the lending market tells a similar story. Availability is loose at 587%, meaning there are nearly six shares available to borrow for every one currently lent out. That is well above the 52-week low of 228% and close to the most permissive borrow conditions of the past year. The cost to borrow has ticked up about 7% over the past month to 0.51%, but that is still a low absolute figure. Taken together, the positioning does not suggest a community of aggressive bears, there is little mechanical pressure and no sign of a squeeze building.

The more interesting signal is in options. Traders have sharply reduced their put-heavy bias. The put/call ratio has dropped to 2.50 from readings above 6.0 for most of the prior five weeks, landing nearly two standard deviations below its 20-day average. For a stock whose options market was heavily skewed toward downside protection through September and into early October, that is a meaningful rotation. The 52-week range runs from 0.59 to 7.07, and today's reading sits much closer to the bullish end, suggesting some of that defensive hedging has been taken off. Whether this is profit-taking on puts after a difficult month or fresh call buying ahead of results is harder to say, but the shift is sharp and recent.

The Street remains cautious, and the target cuts have been broad. In the past two weeks alone, Evercore ISI trimmed its target to $440 from $470 while keeping an Outperform. UBS went further, cutting to $335 from $440 on a Neutral. JP Morgan shaved to $320 from $340. Barclays and Morgan Stanley also moved lower. The mean target across the group now stands at $409, a 37% premium to the current price of $299.53. Ratings are mixed: bulls at Evercore, Citigroup and Barclays are offset by Neutral calls at UBS, JP Morgan and Morgan Stanley. The consensus direction over the past month has been downward revisions, not downgrades, which implies the analysts still believe in the recovery thesis but have trimmed their near-term expectations. Valuation offers some support: the stock trades at a P/E of 7.4 and price-to-book below 1, both low by any sector measure. The EPS surprise factor scores in the 79th percentile, and the 12-month forward EPS year-on-year growth estimate ranks in the 80th, pointing to a company where earnings estimates have been more resilient than the share price move suggests.

Institutional ownership is concentrated at the top. Abrams Capital holds 11.3% of shares as its single largest reported position. BlackRock and Fidelity each hold above 9%, and Harris Associates is near 8.7%. None of these holders reported a significant change recently, though FMR added roughly 218,000 shares through August and American Century added 275,000 through September. The activist register shows no 13D holders. All filings are passive 13G, and the disclosure note applies: stakes are as last reported and a holder below 5% may not file again.

Insider activity in the 90-day window has been modest and tilted to the sell side, with a net of roughly minus $147,000 in value terms. Most transactions are small. The one open-market sale of any size was the Chief Administrative Officer selling 320 shares in early September at around $373, without a 10b5-1 plan. It is not a large enough move to read as a signal, but the absence of any open-market buying at current prices is worth noting given the distance between the stock price and analyst targets.

The next earnings event is logged for February 2027, though the earnings history section shows no price reaction data usable for pattern analysis. Retail attention has risen sharply by its own recent standards, with Wikipedia and ORTEX page views running at a z-score above 2 against the prior 90-day history. That points to elevated interest, not necessarily informed buying, but it is a change worth watching as the stock digests its Q3 results and the market processes the wave of analyst revisions from October.